Pivotal phase 3 trial of ADS-4101 in the patients with epilepsy
Latest Information Update: 22 Mar 2018
At a glance
- Drugs Lacosamide (Primary)
- Indications Epilepsy
- Focus Registrational; Therapeutic Use
- Sponsors Adamas Pharmaceuticals
Most Recent Events
- 22 Mar 2018 New trial record
- 15 Mar 2018 According to Adamas Pharmaceuticals Form 10-K, this trial is anticipated to begin in 2019.